Sonendo Inc (OTCPK:SONX)
$ 1.3525 -0.1975 (-12.74%) Market Cap: 565,000.00 Enterprise Value: 2.70 Mil PE Ratio: 0 PB Ratio: 0.05 GF Score: 36/100

Sonendo Inc at Morgan Stanley Global Healthcare Conference Transcript

Sep 13, 2022 / 06:55PM GMT
Release Date Price: $208 (-6.31%)
Erin Elizabeth Wilson Wright
Morgan Stanley, Research Division - Equity Analyst

Hi, everyone. Good afternoon. Thank you for joining us today. My name is Erin Wright. I'm Morgan Stanley's healthcare services and distribution analyst. I'm pleased to have Sonendo's CEO, Bjarne Bergheim, and then also the COO or CCO?

Michael J. Smith
Sonendo, Inc. - Chief Commercial Officer

CCO.

Erin Elizabeth Wilson Wright
Morgan Stanley, Research Division - Equity Analyst

CCO. Michael Smith, with us today. Sonendo is a commercial-stage medical technology company with a focus on the endodontics market. For important disclosures, please see Morgan Stanley research disclosure website at morganstanley.com. If you have any questions, please reach out to your Morgan Stanley sales representative.

Questions & Answers

Erin Elizabeth Wilson Wright
Morgan Stanley, Research Division - Equity Analyst

With that, thanks for having us -- or thanks. We're happy to have you here. So in terms

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investorsā€™ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot